Abrogation of ionizing radiation-induced G2 checkpoint and inhibition of nuclear export by Cryptocarya pyrones

Christopher M Sturgeon1, Bruno Cinel, Ana R Díaz-Marrero

  • 1Department of Biochemistry and Molecular Biology, Life Sciences Centre, University of British Columbia, Vancouver, BC, Canada.

Insights

New plant compounds, Z-Cryptofolione and Cryptomoscatone D2, inhibit the G(2) checkpoint by blocking nuclear export, offering a novel strategy beyond kinase inhibition for cancer therapy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Pharmacology

Background:

  • The G(2) checkpoint prevents cells with DNA damage from entering mitosis.
  • G(2) checkpoint inhibitors can enhance cancer cell killing by radiation and chemotherapy, especially in p53-deficient cells.
  • Existing inhibitors target checkpoint kinases or phosphatases.

Purpose of the Study:

  • To identify novel G(2) checkpoint inhibitors using a phenotypic cell-based assay.
  • To explore alternative mechanisms for abrogating the G(2) checkpoint.
  • To investigate plant extracts for potential therapeutic compounds.

Main Methods:

  • Phenotypic cell-based screening of plant extracts.
  • Identification and characterization of Z-Cryptofolione and Cryptomoscatone D2.
  • Assessment of nuclear export inhibition.
  • Evaluation of radiosensitizing potential and toxicity.

Main Results:

  • Z-Cryptofolione and Cryptomoscatone D2 were identified as potent G(2) checkpoint inhibitors from plant extracts.
  • These compounds, along with related pyrones, were found to inhibit nuclear export.
  • Leptomycin B, a known nuclear export inhibitor, also potently inhibited the G(2) checkpoint.
  • The identified compounds showed toxicity to unirradiated cells, limiting their radiosensitizing potential.

Conclusions:

  • Inhibition of nuclear export is a viable alternative strategy for abrogating the G(2) checkpoint.
  • This finding warrants further research into developing less toxic nuclear export inhibitors.
  • Novel plant-derived compounds offer new avenues for G(2) checkpoint modulation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...